Biocompatibility and characteristics of chitosan/cellulose acetate microspheres for drug delivery

Abstract

In this work, chitosan/cellulose acetate microspheres (CCAM) were prepared by the method of W/O/W emulsion with no toxic reagents. The microspheres were spherical, free flowing, and non-aggregated, which had a narrow size distribution. More than 90% of the microspheres had the diameter ranging from 200 to 280 μm. The hemolytic analysis indicated that CCAM was safe and had no hemolytic effect. The implanted CCAM did not produce any significant changes in the hematology of Sprague-Dawley (SD) rats, such as white blood cell, red blood cell, platelet, and the volume of hemoglobin. In addition, the levels of serum alanine aminotransferase, blood urea nitrogen, and creatinine had no obvious changes in SD rats implanted with CCAM, surger thread, or normal SD rats without any implantation. Thus, the CCAM had good blood compatibility and had no hepatotoxicity or renal toxicity to SD rats. Furthermore, CCAM with or without the model drug had good tissue compatibility with respect to the inflammatory reaction in SD rats and showed no significant difference from that of SD rats implanted with surgery thread. CCAM shows promise as a long-acting delivery system, which had good biocompatibility and biodegradability.

Keywords

chitosan / cellulose acetate / CCAM / blood compatibility / tissue compatibility

References

[1] Campos M G N, Rawls H R, Innocentini-Mei L H, . In vitro gentamicin sustained and controlled release from chitosan cross-linked films. Journal of Materials Science: Materials in Medicine , 2009, 20(2): 537–542 10.1007/s10856-008-3611-2
[2] Feng F, Liu Y, Zhao B, . In vitro biomineralization of glutaraldehyde crosslinked chitosan/glutamic acid films. Journal of Wuhan University of Technology - Materials Science Edition , 2009, 24(1): 9–14
[3] Kong M, Chen X, Xue Y, . Preparation and antibacterial activity of chitosan microshperes in a solid dispersing system. Frontiers of Materials Science in China , 2008, 2(2): 214–220 10.1007/s11706-008-0036-2
[4] Sezer A D, Akbu?a J. Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): formulation design and release characteristics. AAPS PharmSciTech , 2009, 10(4): 1193–1199 10.1208/s12249-009-9324-0
[5] Sahu S K, Mallick S K, Santra S, . In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. Journal of Materials Science: Materials in Medicine , 2010, 21(5): 1587–1597 10.1007/s10856-010-3998-4
[6] Ieva E, Trapani A, Cioffi N, . Analytical characterization of chitosan nanoparticles for peptide drug delivery applications. Analytical and Bioanalytical Chemistry , 2009, 393(1): 207–215 10.1007/s00216-008-2463-4
[7] ?zcan ?, Abac? ?, Uztan A H, . Enhanced topical delivery of terbinafine hydrochloride with chitosan hydrogels. AAPS PharmSciTech , 2009, 10(3): 1024–1031
[8] Jamnongkan T, Kaewpirom S. Potassium release kinetics and water retention of controlled-release fertilizers based on chitosan hydrogels. Journal of Polymers and the Environment , 2010, 18(3): 413–421 10.1007/s10924-010-0228-6
[9] Wei W, Yuan L, Hu G, . Monodisperse chitosan microspheres with interesting structures for protein drug delivery. Advanced Materials , 2008, 20(12): 2292–2296 10.1002/adma.200702663
[10] Ubaidulla U, Khar R K, Ahmad F J, . Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin. Journal of Pharmaceutical Sciences , 2007, 96(11): 3010–3023 10.1002/jps.20969
[11] Changerath R, Nair P D, Mathew S, . Poly(methyl methacrylate)-grafted chitosan microspheres for controlled release of ampicillin. Journal of Biomedical Materials Research Part B: Applied Biomaterials , 2009, 89B(1): 65–76 10.1002/jbm.b.31188
[12] Yenilmez E, Ba?aran E, Yazan Y. Release characteristics of vitamin E incorporated chitosan microspheres and in vitro-in vivo evaluation for topical application. Carbohydrate Polymers , 2011, 84(2): 807–811 10.1016/j.carbpol.2010.07.002
[13] Inan? B, El?in A E, Ko? A, Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres. Journal of Biomedical Materials Research Part A , 2007, 82A(4): 917–926 10.1002/jbm.a.31213
[14] Kulkarni V H, Kulkarni P V, Keshavayya J, . Glutaraldehyde-crosslinked chitosan beads for controlled release of diclofenac sodium. Journal of Applied Polymer Science , 2007, 103(1): 211–217 10.1002/app.25161
[15] Kulkarni P V, Keshavayya J, Kulkarni V H. Effect of method of preparation and process variables on controlled release of insoluble drug from chitosan microspheres. Polymers for Advanced Technologies , 2007, 18(10): 814–821 10.1002/pat.940
[16] Gupta K C, Jabrail F H. Effect of molecular weight and degree of deacetylation on controlled release of isoniazid from chitosan microspheres. Polymers for Advanced Technologies , 2008, 19(5): 432–441 10.1002/pat.1035
[17] Huang-Lee L L H, Cheung D T, Nimni M E. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks. Journal of Biomedical Materials Research , 1990, 24(9): 1185–1201 10.1002/jbm.820240905
[18] Tsai C-C, Huang R-N, Sung H-W, . In vitro evaluation of the genotoxicity of a naturally occurring crosslinking agent (genipin) for biologic tissue fixation. Journal of Biomedical Materials Research , 2000, 52(1): 58–65 10.1002/1097-4636(200010)52:1<58::AID-JBM8>3.0.CO;2-0
[19] Shu X Z, Zhu K J. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. Journal of Microencapsulation , 2001, 18(2): 237–245 10.1080/02652040010000415
[20] Zhou H Y, Chen X G, Liu C S, . Release characteristics of three model drugs from chitosan/cellulose acetate multimicrospheres. Biochemical Engineering Journal , 2006, 31(3): 228–233 10.1016/j.bej.2006.08.007
[21] Zhou H Y, Chen X G, Zhang W F. In vitro and in vivo evaluation of mucoadhesiveness of chitosan/cellulose acetate multimicrospheres. Journal of Biomedical Materials Research Part A , 2007, 83A(4): 1146–1153 10.1002/jbm.a.31400
[22] Yener G, Incegül T, Yener N. Importance of using solid lipid microspheres as carriers for UV filters on the example octyl methoxy cinnamate. International Journal of Pharmaceutics , 2003, 258(1-2): 203–207 10.1016/S0378-5173(03)00203-5
[23] Mudenda Hang’ombe B, Kohda T, Mukamoto M, . Purification and sensitivity of Clostridium chauvoei hemolysin to various erythrocytes. Comparative Immunology, Microbiology and Infectious Diseases , 2006, 29(4): 263–268
[24] Seibert C S, Shinohara E M G, Sano-Martins I S. In vitro hemolytic activity of Lonomia obliqua caterpillar bristle extract on human and Wistar rat erythrocytes. Toxicon , 2003, 41(7): 831–839 10.1016/S0041-0101(03)00040-0
[25] Zhang W F, Zhou H Y, Chen X G, . Biocompatibility study of theophylline/chitosan/β-cyclodextrin microspheres as pulmonary delivery carriers. Journal of Materials Science: Materials in Medicine , 2009, 20(6): 1321–1330 10.1007/s10856-008-3680-2
[26] Wang Q Z, Chen X G, Li Z X, . Preparation and blood coagulation evaluation of chitosan microspheres. Journal of Materials Science: Materials in Medicine , 2008, 19(3): 1371–1377 10.1007/s10856-007-3243-y
[27] Wang L C, Chen X G, Zhong D Y, . Study on poly(vinyl alcohol)/carboxymethyl-chitosan blend film as local drug delivery system. Journal of Materials Science: Materials in Medicine , 2007, 18(6): 1125–1133 10.1007/s10856-007-0159-5
[28] Li Y Y, Chen X G, Zhang J, . In vitro release of rifampicin and biocompatibility of oleoylchitosan nanoparticles. Journal of Applied Polymer Science , 2009, 111(5): 2269–2274 10.1002/app.29175
[29] Matsuzawa T, Nomura M, Yonezawa H, . Selection of appropriate parameters, use of a quality control concept, and suitable statistical analyses for clinical pathology examination of animals in toxicity studies: results of a current survey by the Japanese Pharmaceutical Manufacturers Association. Comparative Haematology International , 1995, 5(3): 196–200 10.1007/BF00368044
[30] VandeVord P J, Matthew H W T, DeSilva S P, . Evaluation of the biocompatibility of a chitosan scaffold in mice. Journal of Biomedical Materials Research Part A , 2002, 59(3): 585–590 10.1002/jbm.1270
[31] Mi F L, Tan Y C, Liang H F, . In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials , 2002, 23(1): 181–191 10.1016/S0142-9612(01)00094-1
[32] Zhou H Y, Chen X G. Characteristics and degradation of chitosan/cellulose acetate microspheres with different model drugs. Frontiers of Materials Science in China , 2008, 2(4): 417–425 10.1007/s11706-008-0063-z